CD4 and neoplasm: Clearly, weakening Treg cells and effectively activating or restoring effector CD4+ T cell responses are important for successful tumor clearance, and elucidating the mechanism of tumor regulation on CD4+ T cell differentiation might provide new targets for immunotherapy.